- Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration
-
Seong NJ, Yoon CJ, Kang SG, Chung JW, Kim HC, Park JH
- KMID: 1245384
- Korean J Radiol.
- 2012 Apr;13(2):195-201.
- doi: 10.3348/kjr.2012.13.2.195
OBJECTIVE: Arsenic trioxide (As2O3) can be used as a possible pharmaceutical alternative that augments radiofrequency (RF) ablation by reducing tumor blood flow. The aim of this study was to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Anticancer effect of liposome incorporated with methotrexate and antibody against tumor specific surface antigen of rat hepatoma
-
Shin YS, Paik EM, Ahn YH, Kim BS, Kim YS
- KMID: 1097015
- Yonsei Med J.
- 1989 Sep;30(3):246-255.
- doi: 10.3349/ymj.1989.30.3.246
antibody against tumor specific surface membrane protein was produced by immunizing a New Zealand White rabbit with antigen (66 kDa) prepared from the plasma membrane of rat hepatoma induced... -
- CITED
-
- Close
- SHARE
-
- Close
- FDG-PET for Evaluating the Antitumor Effect of Intraarterial 3-Bromopyruvate Administration in a Rabbit VX2 Liver Tumor Model
-
Park HS, Chung JW, Jae HJ, Kim YI, Son KR, Lee MJ, Park JH, Kang WJ, Yoon JH, Chung H, Lee K
- KMID: 1779437
- Korean J Radiol.
- 2007 Jun;8(3):216-224.
- doi: 10.3348/kjr.2007.8.3.216
OBJECTIVE: We wanted to investigate the feasibility of using FDG-PET for evaluating the antitumor effect of intraarterial administration of a hexokinase II inhibitor, 3-bromopyruvate (3-BrPA), in a rabbit VX2 liver... -
- CITED
-
- Close
- SHARE
-
- Close
- The Antitumor Effect and Hepatotoxicity of a Hexokinase II Inhibitor 3-Bromopyruvate: In Vivo Investigation of Intraarterial Administration in a Rabbit VX2 Hepatoma Model
-
Jae HJ, Chung JW, Park HS, Lee MJ, Lee KC, Kim HC, Yoon JH, Chung H, Park JH
- KMID: 1102563
- Korean J Radiol.
- 2009 Dec;10(6):596-603.
- doi: 10.3348/kjr.2009.10.6.596
OBJECTIVE: The purpose of this study was to compare the antitumor effect and hepatotoxicity of an intraarterial delivery of low-dose and high-dose 3-bromopyruvate (3-BrPA) and those of a conventional Lipiodol-doxorubicin... -
- CITED
-
- Close
- SHARE
-
- Close
